PeptidePedia The community reference

User talk:ExenatideEzra

Editor talk page·2 messages

This is the talk page for the editor ExenatideEzra. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

Working group invitation

Given your edits around Research use only, you might find the working-group pages useful — Project:Analytical working group, Project:Pharmacology working group and Project:Clinical evidence working group each keep a short priority list, and the priorities are mostly things one person can finish in an afternoon. — StateBoardStace (talk) 02:15, 22 January 2026 (UTC)

Joined. I have also asked whether the lists are pruned, since two of the items look as though they were done months ago. — ExenatideEzra (talk) 14:04, 23 January 2026 (UTC)

Nomenclature in Dulaglutide

Per Project:Manual of style the international non-proprietary name leads and the trade name follows in parentheses at first mention. Dulaglutide has it the other way round in the lead and the right way round in the body. Not important in itself, but the articles are read side by side. — KarlFischerKit (talk) 04:09, 21 April 2026 (UTC)

Thank you. I have made the same correction on the two sibling articles, which had the same inversion. — ExenatideEzra (talk) 17:01, 21 April 2026 (UTC)